Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma | Zendy

Minjie Ma | Zendy; Yunlang She | Zendy; Yijiu Ren | Zendy; Chenyang Dai | Zendy; Lei Zhang | Zendy; Huikang Xie | Zendy; Chunyan Wu | Zendy; Minglei Yang | Zendy; Dong Xie | Zendy; Chang Chen | Zendy

Open Access

Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma

Author(s) -

Minjie Ma,

Yunlang She,

Yijiu Ren,

Chenyang Dai,

Lei Zhang,

Huikang Xie,

Chunyan Wu,

Minglei Yang,

Dong Xie,

Chang Chen

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.08.64

Subject(s) - medicine , hazard ratio , adenocarcinoma , confidence interval , stage (stratigraphy) , univariate analysis , carcinoembryonic antigen , adjuvant chemotherapy , gastroenterology , multivariate analysis , oncology , chemotherapy , proportional hazards model , adjuvant , lung , subgroup analysis , cancer , paleontology , breast cancer , biology

Our study aimed to evaluate the prognostic significance and adjuvant chemotherapy (ACT) benefits of a micropapillary/solid (MS) pattern in patients with stage IB lung adenocarcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research